Advancing Targeted Care for Adults with Genetically Defined Acute Myeloid Leukemia (AML)

In recognition of AML World Awareness Day, Servier Canada is highlighting the progress made in precision medicine for Acute Myeloid Leukemia (AML).
The American Journal of Managed Care

Patients With AML May Acquire TP53 Mutations Over the Course of Therapy

Over the course of treatment, patients with relapsed/refractory acute myeloid leukemia (AML) may acquire new TP53 mutations, making ongoing monitoring for mutations crucial. “New novel therapies ...